Eptoin 300 ER Tablet contains Phenytoin 300mg, an antiepileptic medication primarily used in the management and prevention of generalized tonic-clonic (grand mal) seizures, complex partial seizures, and status epilepticus. Phenytoin acts by stabilizing the neuronal membrane and reducing seizure activity through the modulation of voltage-dependent sodium channels, thereby limiting the repetitive firing of action potentials in the brain. The extended-release formulation of Eptoin 300 ER ensures a sustained plasma concentration, promoting consistent therapeutic effects and improved patient compliance by reducing dosing frequency. This medication is indicated for both monotherapy and adjunctive therapy in epilepsy management. It is essential to administer Eptoin 300 ER under medical supervision, with careful monitoring of serum phenytoin levels to avoid toxicity, which may manifest as nystagmus, ataxia, or cognitive disturbances. Dose adjustments may be necessary based on clinical response and plasma concentrations. Caution is advised in patients with hepatic impairment, cardiovascular disease, or hypersensitivity to phenytoin. Potential drug interactions include those with other antiepileptics, anticoagulants, and certain antibiotics. Pregnant women should use phenytoin only if clearly needed due to potential teratogenic effects. Overall, Eptoin 300 ER is a critical therapeutic agent in epilepsy management, offering effective seizure control with extended-release benefits.